nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydroxyurea—Leukemia secondary—Epirubicin—liver cancer	0.0528	0.0647	CcSEcCtD
Hydroxyurea—Leukemia secondary—Doxorubicin—liver cancer	0.0488	0.0599	CcSEcCtD
Hydroxyurea—Recall phenomenon—Sorafenib—liver cancer	0.0394	0.0483	CcSEcCtD
Hydroxyurea—Radiation injury—Epirubicin—liver cancer	0.0241	0.0295	CcSEcCtD
Hydroxyurea—Radiation injury—Doxorubicin—liver cancer	0.0223	0.0273	CcSEcCtD
Hydroxyurea—Skin cancer—Sorafenib—liver cancer	0.022	0.027	CcSEcCtD
Hydroxyurea—Metastatic disease—Epirubicin—liver cancer	0.0219	0.0269	CcSEcCtD
Hydroxyurea—Metastatic disease—Doxorubicin—liver cancer	0.0203	0.0249	CcSEcCtD
Hydroxyurea—Ureteric obstruction—Epirubicin—liver cancer	0.0154	0.0189	CcSEcCtD
Hydroxyurea—Urine output—Epirubicin—liver cancer	0.0146	0.0179	CcSEcCtD
Hydroxyurea—Recall phenomenon—Epirubicin—liver cancer	0.0146	0.0179	CcSEcCtD
Hydroxyurea—Ureteric obstruction—Doxorubicin—liver cancer	0.0142	0.0175	CcSEcCtD
Hydroxyurea—Urine output—Doxorubicin—liver cancer	0.0135	0.0165	CcSEcCtD
Hydroxyurea—Recall phenomenon—Doxorubicin—liver cancer	0.0135	0.0165	CcSEcCtD
Hydroxyurea—Metastatic neoplasm—Epirubicin—liver cancer	0.0132	0.0162	CcSEcCtD
Hydroxyurea—Mucosal inflammation—Sorafenib—liver cancer	0.0123	0.0151	CcSEcCtD
Hydroxyurea—Metastatic neoplasm—Doxorubicin—liver cancer	0.0122	0.015	CcSEcCtD
Hydroxyurea—Oligospermia—Epirubicin—liver cancer	0.0121	0.0148	CcSEcCtD
Hydroxyurea—Gastrointestinal symptom NOS—Sorafenib—liver cancer	0.0116	0.0143	CcSEcCtD
Hydroxyurea—Oligospermia—Doxorubicin—liver cancer	0.0112	0.0137	CcSEcCtD
Hydroxyurea—Azoospermia—Epirubicin—liver cancer	0.00938	0.0115	CcSEcCtD
Hydroxyurea—Leukaemia—Epirubicin—liver cancer	0.00938	0.0115	CcSEcCtD
Hydroxyurea—Leukaemia—Doxorubicin—liver cancer	0.00868	0.0106	CcSEcCtD
Hydroxyurea—Azoospermia—Doxorubicin—liver cancer	0.00868	0.0106	CcSEcCtD
Hydroxyurea—RRM2—G1/S-Specific Transcription—PCNA—liver cancer	0.00795	0.043	CbGpPWpGaD
Hydroxyurea—Skin necrosis—Epirubicin—liver cancer	0.00723	0.00887	CcSEcCtD
Hydroxyurea—Skin necrosis—Doxorubicin—liver cancer	0.00669	0.0082	CcSEcCtD
Hydroxyurea—Skin exfoliation—Sorafenib—liver cancer	0.00652	0.008	CcSEcCtD
Hydroxyurea—Neoplasm—Sorafenib—liver cancer	0.00618	0.00758	CcSEcCtD
Hydroxyurea—Hepatic failure—Sorafenib—liver cancer	0.00552	0.00677	CcSEcCtD
Hydroxyurea—RRM1—Fluoropyrimidine Activity—MTHFR—liver cancer	0.0055	0.0298	CbGpPWpGaD
Hydroxyurea—Myelosuppression—Epirubicin—liver cancer	0.00539	0.00661	CcSEcCtD
Hydroxyurea—Renal failure acute—Sorafenib—liver cancer	0.00537	0.00659	CcSEcCtD
Hydroxyurea—Myelosuppression—Doxorubicin—liver cancer	0.00498	0.00611	CcSEcCtD
Hydroxyurea—RRM2—E2F mediated regulation of DNA replication—PCNA—liver cancer	0.00468	0.0253	CbGpPWpGaD
Hydroxyurea—Mucosal inflammation—Epirubicin—liver cancer	0.00456	0.0056	CcSEcCtD
Hydroxyurea—RRM2—Fluoropyrimidine Activity—MTHFR—liver cancer	0.00453	0.0245	CbGpPWpGaD
Hydroxyurea—Breast disorder—Sorafenib—liver cancer	0.00448	0.0055	CcSEcCtD
Hydroxyurea—Skin hyperpigmentation—Epirubicin—liver cancer	0.00425	0.00521	CcSEcCtD
Hydroxyurea—Mucosal inflammation—Doxorubicin—liver cancer	0.00422	0.00518	CcSEcCtD
Hydroxyurea—Pancreatitis—Sorafenib—liver cancer	0.0042	0.00516	CcSEcCtD
Hydroxyurea—Febrile neutropenia—Epirubicin—liver cancer	0.0042	0.00515	CcSEcCtD
Hydroxyurea—Eruption—Epirubicin—liver cancer	0.00411	0.00504	CcSEcCtD
Hydroxyurea—Neutropenia—Sorafenib—liver cancer	0.00401	0.00492	CcSEcCtD
Hydroxyurea—Hypomagnesaemia—Epirubicin—liver cancer	0.00398	0.00488	CcSEcCtD
Hydroxyurea—Skin hyperpigmentation—Doxorubicin—liver cancer	0.00393	0.00482	CcSEcCtD
Hydroxyurea—Febrile neutropenia—Doxorubicin—liver cancer	0.00388	0.00477	CcSEcCtD
Hydroxyurea—Infestation NOS—Sorafenib—liver cancer	0.00382	0.00469	CcSEcCtD
Hydroxyurea—Infestation—Sorafenib—liver cancer	0.00382	0.00469	CcSEcCtD
Hydroxyurea—Eruption—Doxorubicin—liver cancer	0.0038	0.00466	CcSEcCtD
Hydroxyurea—Neuropathy peripheral—Sorafenib—liver cancer	0.00375	0.0046	CcSEcCtD
Hydroxyurea—Bone marrow depression—Epirubicin—liver cancer	0.00374	0.00459	CcSEcCtD
Hydroxyurea—Stomatitis—Sorafenib—liver cancer	0.00373	0.00457	CcSEcCtD
Hydroxyurea—Hypomagnesaemia—Doxorubicin—liver cancer	0.00368	0.00451	CcSEcCtD
Hydroxyurea—Hepatobiliary disease—Sorafenib—liver cancer	0.00362	0.00444	CcSEcCtD
Hydroxyurea—Blister—Epirubicin—liver cancer	0.0035	0.0043	CcSEcCtD
Hydroxyurea—Bone marrow depression—Doxorubicin—liver cancer	0.00346	0.00425	CcSEcCtD
Hydroxyurea—Haemoglobin—Sorafenib—liver cancer	0.00345	0.00423	CcSEcCtD
Hydroxyurea—Haemorrhage—Sorafenib—liver cancer	0.00343	0.00421	CcSEcCtD
Hydroxyurea—Skin ulcer—Epirubicin—liver cancer	0.00324	0.00398	CcSEcCtD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—FST—liver cancer	0.00324	0.0175	CbGpPWpGaD
Hydroxyurea—Blister—Doxorubicin—liver cancer	0.00324	0.00398	CcSEcCtD
Hydroxyurea—Angiopathy—Sorafenib—liver cancer	0.00311	0.00382	CcSEcCtD
Hydroxyurea—CYP2D6—CYP2E1 reactions—CYP2E1—liver cancer	0.0031	0.0168	CbGpPWpGaD
Hydroxyurea—RRM1—Retinoblastoma (RB) in Cancer—ABL1—liver cancer	0.00305	0.0165	CbGpPWpGaD
Hydroxyurea—Alopecia—Sorafenib—liver cancer	0.00303	0.00372	CcSEcCtD
Hydroxyurea—Skin ulcer—Doxorubicin—liver cancer	0.003	0.00368	CcSEcCtD
Hydroxyurea—Erythema—Sorafenib—liver cancer	0.00299	0.00366	CcSEcCtD
Hydroxyurea—Amenorrhoea—Epirubicin—liver cancer	0.00287	0.00353	CcSEcCtD
Hydroxyurea—RRM2—G1/S Transition—PSMA4—liver cancer	0.00284	0.0154	CbGpPWpGaD
Hydroxyurea—RRM2—G1/S Transition—PSMD10—liver cancer	0.00284	0.0154	CbGpPWpGaD
Hydroxyurea—Anaemia—Sorafenib—liver cancer	0.00276	0.00339	CcSEcCtD
Hydroxyurea—Hyperuricaemia—Epirubicin—liver cancer	0.00272	0.00334	CcSEcCtD
Hydroxyurea—Leukopenia—Sorafenib—liver cancer	0.00267	0.00328	CcSEcCtD
Hydroxyurea—Ulcer—Epirubicin—liver cancer	0.00267	0.00328	CcSEcCtD
Hydroxyurea—Amenorrhoea—Doxorubicin—liver cancer	0.00266	0.00326	CcSEcCtD
Hydroxyurea—Creatinine increased—Epirubicin—liver cancer	0.00265	0.00325	CcSEcCtD
Hydroxyurea—RRM1—Retinoblastoma (RB) in Cancer—PCNA—liver cancer	0.00262	0.0141	CbGpPWpGaD
Hydroxyurea—Blood uric acid increased—Epirubicin—liver cancer	0.00257	0.00316	CcSEcCtD
Hydroxyurea—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—liver cancer	0.00253	0.0031	CcSEcCtD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—HNF4A—liver cancer	0.00252	0.0136	CbGpPWpGaD
Hydroxyurea—Hyperuricaemia—Doxorubicin—liver cancer	0.00252	0.00309	CcSEcCtD
Hydroxyurea—RRM2—Retinoblastoma (RB) in Cancer—ABL1—liver cancer	0.00251	0.0136	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—HPGDS—liver cancer	0.00247	0.0134	CbGpPWpGaD
Hydroxyurea—Ulcer—Doxorubicin—liver cancer	0.00247	0.00303	CcSEcCtD
Hydroxyurea—Creatinine increased—Doxorubicin—liver cancer	0.00245	0.00301	CcSEcCtD
Hydroxyurea—Infection—Sorafenib—liver cancer	0.00242	0.00297	CcSEcCtD
Hydroxyurea—Skin exfoliation—Epirubicin—liver cancer	0.00241	0.00296	CcSEcCtD
Hydroxyurea—RRM2—Mitotic G1-G1/S phases—PSMD10—liver cancer	0.0024	0.013	CbGpPWpGaD
Hydroxyurea—RRM2—Mitotic G1-G1/S phases—PSMA4—liver cancer	0.0024	0.013	CbGpPWpGaD
Hydroxyurea—Nervous system disorder—Sorafenib—liver cancer	0.00239	0.00293	CcSEcCtD
Hydroxyurea—Thrombocytopenia—Sorafenib—liver cancer	0.00239	0.00293	CcSEcCtD
Hydroxyurea—Blood urea increased—Epirubicin—liver cancer	0.00238	0.00293	CcSEcCtD
Hydroxyurea—Blood uric acid increased—Doxorubicin—liver cancer	0.00238	0.00292	CcSEcCtD
Hydroxyurea—Skin disorder—Sorafenib—liver cancer	0.00237	0.00291	CcSEcCtD
Hydroxyurea—Anorexia—Sorafenib—liver cancer	0.00232	0.00285	CcSEcCtD
Hydroxyurea—CYP2D6—Fatty Acid Omega Oxidation—CYP2E1—liver cancer	0.0023	0.0124	CbGpPWpGaD
Hydroxyurea—Rash maculo-papular—Epirubicin—liver cancer	0.0023	0.00282	CcSEcCtD
Hydroxyurea—Neoplasm—Epirubicin—liver cancer	0.00228	0.0028	CcSEcCtD
Hydroxyurea—Pulmonary oedema—Epirubicin—liver cancer	0.00225	0.00276	CcSEcCtD
Hydroxyurea—Skin exfoliation—Doxorubicin—liver cancer	0.00223	0.00274	CcSEcCtD
Hydroxyurea—Blood urea increased—Doxorubicin—liver cancer	0.00221	0.00271	CcSEcCtD
Hydroxyurea—Dyspnoea—Sorafenib—liver cancer	0.00217	0.00267	CcSEcCtD
Hydroxyurea—RRM2—Retinoblastoma (RB) in Cancer—PCNA—liver cancer	0.00215	0.0116	CbGpPWpGaD
Hydroxyurea—Dyspepsia—Sorafenib—liver cancer	0.00215	0.00263	CcSEcCtD
Hydroxyurea—RRM1—E2F transcription factor network—SERPINE1—liver cancer	0.00213	0.0115	CbGpPWpGaD
Hydroxyurea—Rash maculo-papular—Doxorubicin—liver cancer	0.00212	0.00261	CcSEcCtD
Hydroxyurea—Decreased appetite—Sorafenib—liver cancer	0.00212	0.0026	CcSEcCtD
Hydroxyurea—Neoplasm—Doxorubicin—liver cancer	0.00211	0.00259	CcSEcCtD
Hydroxyurea—Gastrointestinal disorder—Sorafenib—liver cancer	0.0021	0.00258	CcSEcCtD
Hydroxyurea—Fatigue—Sorafenib—liver cancer	0.0021	0.00258	CcSEcCtD
Hydroxyurea—RRM1—Fluoropyrimidine Activity—TP53—liver cancer	0.00209	0.0113	CbGpPWpGaD
Hydroxyurea—Constipation—Sorafenib—liver cancer	0.00208	0.00256	CcSEcCtD
Hydroxyurea—Pain—Sorafenib—liver cancer	0.00208	0.00256	CcSEcCtD
Hydroxyurea—Pulmonary oedema—Doxorubicin—liver cancer	0.00208	0.00255	CcSEcCtD
Hydroxyurea—Hepatic failure—Epirubicin—liver cancer	0.00204	0.0025	CcSEcCtD
Hydroxyurea—RRM1—E2F transcription factor network—CDKN2A—liver cancer	0.00199	0.0108	CbGpPWpGaD
Hydroxyurea—Renal failure acute—Epirubicin—liver cancer	0.00199	0.00244	CcSEcCtD
Hydroxyurea—Body temperature increased—Sorafenib—liver cancer	0.00193	0.00236	CcSEcCtD
Hydroxyurea—CYP2D6—Xenobiotics—CYP2E1—liver cancer	0.00192	0.0104	CbGpPWpGaD
Hydroxyurea—Dermatitis bullous—Epirubicin—liver cancer	0.00192	0.00235	CcSEcCtD
Hydroxyurea—Hepatic failure—Doxorubicin—liver cancer	0.00189	0.00232	CcSEcCtD
Hydroxyurea—CYP2D6—Tamoxifen metabolism—CYP2E1—liver cancer	0.00185	0.01	CbGpPWpGaD
Hydroxyurea—Renal failure acute—Doxorubicin—liver cancer	0.00184	0.00225	CcSEcCtD
Hydroxyurea—RRM2—G1/S Transition—PCNA—liver cancer	0.0018	0.00973	CbGpPWpGaD
Hydroxyurea—Hypersensitivity—Sorafenib—liver cancer	0.0018	0.0022	CcSEcCtD
Hydroxyurea—Dermatitis bullous—Doxorubicin—liver cancer	0.00177	0.00218	CcSEcCtD
Hydroxyurea—Face oedema—Epirubicin—liver cancer	0.00177	0.00217	CcSEcCtD
Hydroxyurea—RRM1—E2F transcription factor network—CDKN1B—liver cancer	0.00176	0.00953	CbGpPWpGaD
Hydroxyurea—RRM2—E2F transcription factor network—SERPINE1—liver cancer	0.00175	0.00948	CbGpPWpGaD
Hydroxyurea—Asthenia—Sorafenib—liver cancer	0.00175	0.00215	CcSEcCtD
Hydroxyurea—RRM2—Fluoropyrimidine Activity—TP53—liver cancer	0.00172	0.0093	CbGpPWpGaD
Hydroxyurea—Blood creatinine increased—Epirubicin—liver cancer	0.00172	0.00211	CcSEcCtD
Hydroxyurea—RRM1—Retinoblastoma (RB) in Cancer—RAF1—liver cancer	0.00167	0.00903	CbGpPWpGaD
Hydroxyurea—Diarrhoea—Sorafenib—liver cancer	0.00167	0.00205	CcSEcCtD
Hydroxyurea—Breast disorder—Epirubicin—liver cancer	0.00166	0.00203	CcSEcCtD
Hydroxyurea—CYP2D6—Fatty Acid Omega Oxidation—CYP1A1—liver cancer	0.00165	0.00894	CbGpPWpGaD
Hydroxyurea—Face oedema—Doxorubicin—liver cancer	0.00164	0.00201	CcSEcCtD
Hydroxyurea—RRM2—E2F transcription factor network—CDKN2A—liver cancer	0.00164	0.00886	CbGpPWpGaD
Hydroxyurea—RRM1—E2F transcription factor network—CDKN1A—liver cancer	0.00163	0.00879	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—ABL1—liver cancer	0.00163	0.00879	CbGpPWpGaD
Hydroxyurea—Dizziness—Sorafenib—liver cancer	0.00161	0.00198	CcSEcCtD
Hydroxyurea—Blood creatinine increased—Doxorubicin—liver cancer	0.00159	0.00195	CcSEcCtD
Hydroxyurea—Pancreatitis—Epirubicin—liver cancer	0.00155	0.00191	CcSEcCtD
Hydroxyurea—Vomiting—Sorafenib—liver cancer	0.00155	0.0019	CcSEcCtD
Hydroxyurea—Rash—Sorafenib—liver cancer	0.00154	0.00189	CcSEcCtD
Hydroxyurea—Dermatitis—Sorafenib—liver cancer	0.00154	0.00188	CcSEcCtD
Hydroxyurea—Breast disorder—Doxorubicin—liver cancer	0.00153	0.00188	CcSEcCtD
Hydroxyurea—RRM1—Retinoblastoma (RB) in Cancer—CDKN1B—liver cancer	0.00153	0.00828	CbGpPWpGaD
Hydroxyurea—Headache—Sorafenib—liver cancer	0.00153	0.00187	CcSEcCtD
Hydroxyurea—RRM2—Mitotic G1-G1/S phases—PCNA—liver cancer	0.00152	0.0082	CbGpPWpGaD
Hydroxyurea—Pancytopenia—Epirubicin—liver cancer	0.0015	0.00185	CcSEcCtD
Hydroxyurea—Neutropenia—Epirubicin—liver cancer	0.00148	0.00182	CcSEcCtD
Hydroxyurea—Dysuria—Epirubicin—liver cancer	0.00148	0.00182	CcSEcCtD
Hydroxyurea—CYP2D6—Cytochrome P450 - arranged by substrate type—NR1H4—liver cancer	0.00147	0.00793	CbGpPWpGaD
Hydroxyurea—RRM1—Retinoblastoma (RB) in Cancer—CCND1—liver cancer	0.00146	0.0079	CbGpPWpGaD
Hydroxyurea—RRM2—E2F transcription factor network—CDKN1B—liver cancer	0.00145	0.00784	CbGpPWpGaD
Hydroxyurea—Nausea—Sorafenib—liver cancer	0.00145	0.00178	CcSEcCtD
Hydroxyurea—Weight increased—Epirubicin—liver cancer	0.00144	0.00177	CcSEcCtD
Hydroxyurea—Pancreatitis—Doxorubicin—liver cancer	0.00144	0.00176	CcSEcCtD
Hydroxyurea—Infestation—Epirubicin—liver cancer	0.00141	0.00173	CcSEcCtD
Hydroxyurea—Infestation NOS—Epirubicin—liver cancer	0.00141	0.00173	CcSEcCtD
Hydroxyurea—Drowsiness—Epirubicin—liver cancer	0.00141	0.00173	CcSEcCtD
Hydroxyurea—RRM1—Retinoblastoma (RB) in Cancer—CDKN1A—liver cancer	0.00141	0.00764	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—PCNA—liver cancer	0.00139	0.00754	CbGpPWpGaD
Hydroxyurea—Pancytopenia—Doxorubicin—liver cancer	0.00139	0.00171	CcSEcCtD
Hydroxyurea—Neuropathy peripheral—Epirubicin—liver cancer	0.00138	0.0017	CcSEcCtD
Hydroxyurea—CYP2D6—Xenobiotics—CYP1A1—liver cancer	0.00138	0.00748	CbGpPWpGaD
Hydroxyurea—Stomatitis—Epirubicin—liver cancer	0.00138	0.00169	CcSEcCtD
Hydroxyurea—RRM2—Retinoblastoma (RB) in Cancer—RAF1—liver cancer	0.00138	0.00744	CbGpPWpGaD
Hydroxyurea—Dysuria—Doxorubicin—liver cancer	0.00137	0.00168	CcSEcCtD
Hydroxyurea—Neutropenia—Doxorubicin—liver cancer	0.00137	0.00168	CcSEcCtD
Hydroxyurea—RRM1—E2F transcription factor network—MYC—liver cancer	0.00135	0.00729	CbGpPWpGaD
Hydroxyurea—RRM2—E2F transcription factor network—CDKN1A—liver cancer	0.00134	0.00724	CbGpPWpGaD
Hydroxyurea—Hepatobiliary disease—Epirubicin—liver cancer	0.00134	0.00164	CcSEcCtD
Hydroxyurea—Weight increased—Doxorubicin—liver cancer	0.00133	0.00164	CcSEcCtD
Hydroxyurea—CYP2D6—Tamoxifen metabolism—CYP1A1—liver cancer	0.00133	0.00719	CbGpPWpGaD
Hydroxyurea—Infestation NOS—Doxorubicin—liver cancer	0.00131	0.0016	CcSEcCtD
Hydroxyurea—Drowsiness—Doxorubicin—liver cancer	0.00131	0.0016	CcSEcCtD
Hydroxyurea—Infestation—Doxorubicin—liver cancer	0.00131	0.0016	CcSEcCtD
Hydroxyurea—Neuropathy peripheral—Doxorubicin—liver cancer	0.00128	0.00157	CcSEcCtD
Hydroxyurea—Haemoglobin—Epirubicin—liver cancer	0.00127	0.00156	CcSEcCtD
Hydroxyurea—Stomatitis—Doxorubicin—liver cancer	0.00127	0.00156	CcSEcCtD
Hydroxyurea—Haemorrhage—Epirubicin—liver cancer	0.00127	0.00156	CcSEcCtD
Hydroxyurea—RRM2—Retinoblastoma (RB) in Cancer—CDKN1B—liver cancer	0.00126	0.00682	CbGpPWpGaD
Hydroxyurea—Hepatobiliary disease—Doxorubicin—liver cancer	0.00124	0.00152	CcSEcCtD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—MAPK14—liver cancer	0.00122	0.00662	CbGpPWpGaD
Hydroxyurea—RRM2—Retinoblastoma (RB) in Cancer—CCND1—liver cancer	0.0012	0.0065	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—ESR1—liver cancer	0.0012	0.00649	CbGpPWpGaD
Hydroxyurea—CYP2D6—Phase 1 - Functionalization of compounds—NR1H4—liver cancer	0.00119	0.00643	CbGpPWpGaD
Hydroxyurea—Haemoglobin—Doxorubicin—liver cancer	0.00118	0.00145	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—UGDH—liver cancer	0.00118	0.00637	CbGpPWpGaD
Hydroxyurea—Haemorrhage—Doxorubicin—liver cancer	0.00117	0.00144	CcSEcCtD
Hydroxyurea—RRM1—Retinoblastoma (RB) in Cancer—MYC—liver cancer	0.00117	0.00633	CbGpPWpGaD
Hydroxyurea—RRM2—Retinoblastoma (RB) in Cancer—CDKN1A—liver cancer	0.00116	0.00629	CbGpPWpGaD
Hydroxyurea—Angiopathy—Epirubicin—liver cancer	0.00115	0.00141	CcSEcCtD
Hydroxyurea—Chills—Epirubicin—liver cancer	0.00114	0.0014	CcSEcCtD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—APC—liver cancer	0.00113	0.00614	CbGpPWpGaD
Hydroxyurea—Alopecia—Epirubicin—liver cancer	0.00112	0.00137	CcSEcCtD
Hydroxyurea—RRM2—E2F transcription factor network—MYC—liver cancer	0.00111	0.006	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—EPT1—liver cancer	0.00111	0.00599	CbGpPWpGaD
Hydroxyurea—Erythema—Epirubicin—liver cancer	0.0011	0.00135	CcSEcCtD
Hydroxyurea—CYP2D6—Biological oxidations—UGDH—liver cancer	0.00108	0.00585	CbGpPWpGaD
Hydroxyurea—Angiopathy—Doxorubicin—liver cancer	0.00106	0.00131	CcSEcCtD
Hydroxyurea—Chills—Doxorubicin—liver cancer	0.00105	0.00129	CcSEcCtD
Hydroxyurea—RRM2—G1/S Transition—CDKN1B—liver cancer	0.00105	0.00569	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—TAT—liver cancer	0.00105	0.00568	CbGpPWpGaD
Hydroxyurea—Alopecia—Doxorubicin—liver cancer	0.00104	0.00127	CcSEcCtD
Hydroxyurea—CYP2D6—Melatonin metabolism and effects—CYP1A1—liver cancer	0.00103	0.00555	CbGpPWpGaD
Hydroxyurea—Ill-defined disorder—Epirubicin—liver cancer	0.00102	0.00126	CcSEcCtD
Hydroxyurea—Erythema—Doxorubicin—liver cancer	0.00102	0.00125	CcSEcCtD
Hydroxyurea—Anaemia—Epirubicin—liver cancer	0.00102	0.00125	CcSEcCtD
Hydroxyurea—RRM2—Mitotic G1-G1/S phases—CDKN2A—liver cancer	0.001	0.00542	CbGpPWpGaD
Hydroxyurea—Malaise—Epirubicin—liver cancer	0.000996	0.00122	CcSEcCtD
Hydroxyurea—Leukopenia—Epirubicin—liver cancer	0.000988	0.00121	CcSEcCtD
Hydroxyurea—RRM2—G1/S Transition—CDKN1A—liver cancer	0.000971	0.00525	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—UGDH—liver cancer	0.00097	0.00525	CbGpPWpGaD
Hydroxyurea—RRM2—Retinoblastoma (RB) in Cancer—MYC—liver cancer	0.000964	0.00522	CbGpPWpGaD
Hydroxyurea—RRM1—Retinoblastoma (RB) in Cancer—TP53—liver cancer	0.000962	0.0052	CbGpPWpGaD
Hydroxyurea—Convulsion—Epirubicin—liver cancer	0.000957	0.00117	CcSEcCtD
Hydroxyurea—Ill-defined disorder—Doxorubicin—liver cancer	0.000948	0.00116	CcSEcCtD
Hydroxyurea—Anaemia—Doxorubicin—liver cancer	0.000944	0.00116	CcSEcCtD
Hydroxyurea—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.000933	0.00115	CcSEcCtD
Hydroxyurea—Discomfort—Epirubicin—liver cancer	0.000929	0.00114	CcSEcCtD
Hydroxyurea—Malaise—Doxorubicin—liver cancer	0.000921	0.00113	CcSEcCtD
Hydroxyurea—Leukopenia—Doxorubicin—liver cancer	0.000914	0.00112	CcSEcCtD
Hydroxyurea—RRM2—Metabolism—EPT1—liver cancer	0.000912	0.00493	CbGpPWpGaD
Hydroxyurea—Oedema—Epirubicin—liver cancer	0.000901	0.00111	CcSEcCtD
Hydroxyurea—Infection—Epirubicin—liver cancer	0.000895	0.0011	CcSEcCtD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—RAF1—liver cancer	0.00089	0.00482	CbGpPWpGaD
Hydroxyurea—RRM2—Mitotic G1-G1/S phases—CDKN1B—liver cancer	0.000887	0.0048	CbGpPWpGaD
Hydroxyurea—Convulsion—Doxorubicin—liver cancer	0.000885	0.00109	CcSEcCtD
Hydroxyurea—Nervous system disorder—Epirubicin—liver cancer	0.000884	0.00108	CcSEcCtD
Hydroxyurea—Thrombocytopenia—Epirubicin—liver cancer	0.000882	0.00108	CcSEcCtD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—PSMD10—liver cancer	0.000879	0.00475	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—PSMA4—liver cancer	0.000879	0.00475	CbGpPWpGaD
Hydroxyurea—Skin disorder—Epirubicin—liver cancer	0.000875	0.00107	CcSEcCtD
Hydroxyurea—RRM2—Metabolism—TAT—liver cancer	0.000865	0.00468	CbGpPWpGaD
Hydroxyurea—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.000864	0.00106	CcSEcCtD
Hydroxyurea—Discomfort—Doxorubicin—liver cancer	0.000859	0.00105	CcSEcCtD
Hydroxyurea—Anorexia—Epirubicin—liver cancer	0.000859	0.00105	CcSEcCtD
Hydroxyurea—RRM2—Mitotic G1-G1/S phases—CCND1—liver cancer	0.000846	0.00458	CbGpPWpGaD
Hydroxyurea—Oedema—Doxorubicin—liver cancer	0.000834	0.00102	CcSEcCtD
Hydroxyurea—Infection—Doxorubicin—liver cancer	0.000828	0.00102	CcSEcCtD
Hydroxyurea—RRM2—Mitotic G1-G1/S phases—CDKN1A—liver cancer	0.000818	0.00443	CbGpPWpGaD
Hydroxyurea—Nervous system disorder—Doxorubicin—liver cancer	0.000818	0.001	CcSEcCtD
Hydroxyurea—Thrombocytopenia—Doxorubicin—liver cancer	0.000816	0.001	CcSEcCtD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—CDKN1B—liver cancer	0.000816	0.00441	CbGpPWpGaD
Hydroxyurea—Skin disorder—Doxorubicin—liver cancer	0.00081	0.000994	CcSEcCtD
Hydroxyurea—RRM2—G1/S Transition—MYC—liver cancer	0.000805	0.00436	CbGpPWpGaD
Hydroxyurea—Dyspnoea—Epirubicin—liver cancer	0.000803	0.000986	CcSEcCtD
Hydroxyurea—Somnolence—Epirubicin—liver cancer	0.000801	0.000983	CcSEcCtD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—CASP3—liver cancer	0.0008	0.00432	CbGpPWpGaD
Hydroxyurea—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2E1—liver cancer	0.000799	0.00432	CbGpPWpGaD
Hydroxyurea—Anorexia—Doxorubicin—liver cancer	0.000795	0.000975	CcSEcCtD
Hydroxyurea—Dyspepsia—Epirubicin—liver cancer	0.000793	0.000973	CcSEcCtD
Hydroxyurea—RRM2—Retinoblastoma (RB) in Cancer—TP53—liver cancer	0.000792	0.00428	CbGpPWpGaD
Hydroxyurea—CYP2D6—Oxidation by Cytochrome P450—CYP2E1—liver cancer	0.000788	0.00426	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle—PSMA4—liver cancer	0.000786	0.00425	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle—PSMD10—liver cancer	0.000786	0.00425	CbGpPWpGaD
Hydroxyurea—Decreased appetite—Epirubicin—liver cancer	0.000783	0.000961	CcSEcCtD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—CCND1—liver cancer	0.000778	0.00421	CbGpPWpGaD
Hydroxyurea—Gastrointestinal disorder—Epirubicin—liver cancer	0.000778	0.000954	CcSEcCtD
Hydroxyurea—Fatigue—Epirubicin—liver cancer	0.000777	0.000953	CcSEcCtD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—JUN—liver cancer	0.000777	0.0042	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—CTNNB1—liver cancer	0.000771	0.00417	CbGpPWpGaD
Hydroxyurea—Pain—Epirubicin—liver cancer	0.000771	0.000945	CcSEcCtD
Hydroxyurea—Constipation—Epirubicin—liver cancer	0.000771	0.000945	CcSEcCtD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—CDKN1A—liver cancer	0.000753	0.00407	CbGpPWpGaD
Hydroxyurea—Dyspnoea—Doxorubicin—liver cancer	0.000743	0.000912	CcSEcCtD
Hydroxyurea—Feeling abnormal—Epirubicin—liver cancer	0.000743	0.000911	CcSEcCtD
Hydroxyurea—Somnolence—Doxorubicin—liver cancer	0.000741	0.000909	CcSEcCtD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—MAPK8—liver cancer	0.000735	0.00397	CbGpPWpGaD
Hydroxyurea—Dyspepsia—Doxorubicin—liver cancer	0.000734	0.0009	CcSEcCtD
Hydroxyurea—Decreased appetite—Doxorubicin—liver cancer	0.000725	0.000889	CcSEcCtD
Hydroxyurea—Gastrointestinal disorder—Doxorubicin—liver cancer	0.00072	0.000883	CcSEcCtD
Hydroxyurea—Fatigue—Doxorubicin—liver cancer	0.000719	0.000882	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—CPT1B—liver cancer	0.000714	0.00386	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—GLUL—liver cancer	0.000714	0.00386	CbGpPWpGaD
Hydroxyurea—Pain—Doxorubicin—liver cancer	0.000713	0.000875	CcSEcCtD
Hydroxyurea—Constipation—Doxorubicin—liver cancer	0.000713	0.000875	CcSEcCtD
Hydroxyurea—Body temperature increased—Epirubicin—liver cancer	0.000712	0.000874	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—NR1H4—liver cancer	0.000688	0.00372	CbGpPWpGaD
Hydroxyurea—Feeling abnormal—Doxorubicin—liver cancer	0.000687	0.000843	CcSEcCtD
Hydroxyurea—RRM2—Mitotic G1-G1/S phases—MYC—liver cancer	0.000679	0.00367	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—VEGFA—liver cancer	0.000679	0.00367	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—GSTA3—liver cancer	0.000677	0.00366	CbGpPWpGaD
Hydroxyurea—Hypersensitivity—Epirubicin—liver cancer	0.000664	0.000814	CcSEcCtD
Hydroxyurea—Body temperature increased—Doxorubicin—liver cancer	0.000659	0.000809	CcSEcCtD
Hydroxyurea—CYP2D6—Phase 1 - Functionalization of compounds—CYP2E1—liver cancer	0.000648	0.0035	CbGpPWpGaD
Hydroxyurea—Asthenia—Epirubicin—liver cancer	0.000646	0.000793	CcSEcCtD
Hydroxyurea—CYP2D6—Biological oxidations—NR1H4—liver cancer	0.000631	0.00342	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—MYC—liver cancer	0.000624	0.00338	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—TGFB1—liver cancer	0.000623	0.00337	CbGpPWpGaD
Hydroxyurea—CYP2D6—Biological oxidations—GSTA3—liver cancer	0.000621	0.00336	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—GSTA4—liver cancer	0.000619	0.00335	CbGpPWpGaD
Hydroxyurea—Diarrhoea—Epirubicin—liver cancer	0.000617	0.000756	CcSEcCtD
Hydroxyurea—Hypersensitivity—Doxorubicin—liver cancer	0.000614	0.000754	CcSEcCtD
Hydroxyurea—CYP2D6—Metapathway biotransformation—GSTA3—liver cancer	0.000612	0.00331	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—GSTA2—liver cancer	0.000603	0.00326	CbGpPWpGaD
Hydroxyurea—Asthenia—Doxorubicin—liver cancer	0.000598	0.000734	CcSEcCtD
Hydroxyurea—Dizziness—Epirubicin—liver cancer	0.000596	0.000731	CcSEcCtD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—H2AFX—liver cancer	0.000594	0.00321	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—CPT1B—liver cancer	0.000588	0.00318	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—GLUL—liver cancer	0.000588	0.00318	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—GSTA1—liver cancer	0.000582	0.00315	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—TNF—liver cancer	0.000582	0.00315	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—KRAS—liver cancer	0.000577	0.00312	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—NAT2—liver cancer	0.000575	0.00311	CbGpPWpGaD
Hydroxyurea—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A1—liver cancer	0.000574	0.0031	CbGpPWpGaD
Hydroxyurea—Vomiting—Epirubicin—liver cancer	0.000573	0.000703	CcSEcCtD
Hydroxyurea—Diarrhoea—Doxorubicin—liver cancer	0.00057	0.0007	CcSEcCtD
Hydroxyurea—Rash—Epirubicin—liver cancer	0.000568	0.000697	CcSEcCtD
Hydroxyurea—CYP2D6—Biological oxidations—GSTA4—liver cancer	0.000568	0.00307	CbGpPWpGaD
Hydroxyurea—Dermatitis—Epirubicin—liver cancer	0.000568	0.000696	CcSEcCtD
Hydroxyurea—RRM2—Metabolism—NR1H4—liver cancer	0.000567	0.00307	CbGpPWpGaD
Hydroxyurea—CYP2D6—Oxidation by Cytochrome P450—CYP1A1—liver cancer	0.000566	0.00306	CbGpPWpGaD
Hydroxyurea—Headache—Epirubicin—liver cancer	0.000564	0.000693	CcSEcCtD
Hydroxyurea—CYP2D6—Metapathway biotransformation—GSTA4—liver cancer	0.00056	0.00303	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—GSTA3—liver cancer	0.000557	0.00301	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—PCNA—liver cancer	0.000556	0.00301	CbGpPWpGaD
Hydroxyurea—CYP2D6—Biological oxidations—GSTA2—liver cancer	0.000553	0.00299	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—ALDOB—liver cancer	0.000552	0.00298	CbGpPWpGaD
Hydroxyurea—Dizziness—Doxorubicin—liver cancer	0.000551	0.000676	CcSEcCtD
Hydroxyurea—Nausea—Epirubicin—liver cancer	0.000535	0.000657	CcSEcCtD
Hydroxyurea—CYP2D6—Biological oxidations—GSTA1—liver cancer	0.000534	0.00289	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle—H2AFX—liver cancer	0.000531	0.00287	CbGpPWpGaD
Hydroxyurea—Vomiting—Doxorubicin—liver cancer	0.00053	0.00065	CcSEcCtD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—PIK3CA—liver cancer	0.00053	0.00287	CbGpPWpGaD
Hydroxyurea—CYP2D6—Biological oxidations—NAT2—liver cancer	0.000528	0.00285	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—CRABP1—liver cancer	0.000526	0.00285	CbGpPWpGaD
Hydroxyurea—Rash—Doxorubicin—liver cancer	0.000526	0.000645	CcSEcCtD
Hydroxyurea—Dermatitis—Doxorubicin—liver cancer	0.000525	0.000644	CcSEcCtD
Hydroxyurea—Headache—Doxorubicin—liver cancer	0.000522	0.000641	CcSEcCtD
Hydroxyurea—CYP2D6—Metapathway biotransformation—NAT2—liver cancer	0.000521	0.00282	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—TP53—liver cancer	0.000513	0.00277	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—GSTA4—liver cancer	0.00051	0.00276	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle—PCNA—liver cancer	0.000497	0.00269	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—GSTA2—liver cancer	0.000497	0.00269	CbGpPWpGaD
Hydroxyurea—Nausea—Doxorubicin—liver cancer	0.000495	0.000608	CcSEcCtD
Hydroxyurea—RRM2—Cell Cycle—TERT—liver cancer	0.00048	0.0026	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—GSTA1—liver cancer	0.000479	0.00259	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—NAT2—liver cancer	0.000474	0.00256	CbGpPWpGaD
Hydroxyurea—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—liver cancer	0.000465	0.00252	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—HPGDS—liver cancer	0.00046	0.00249	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—ALDOB—liver cancer	0.000454	0.00246	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metapathway biotransformation—GPX3—liver cancer	0.000443	0.00239	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—CRABP1—liver cancer	0.000433	0.00234	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—AKT1—liver cancer	0.000433	0.00234	CbGpPWpGaD
Hydroxyurea—CYP2D6—Biological oxidations—HPGDS—liver cancer	0.000422	0.00228	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—PSMD10—liver cancer	0.00041	0.00222	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—PSMA4—liver cancer	0.00041	0.00222	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—GOT2—liver cancer	0.000399	0.00216	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—HPGDS—liver cancer	0.000379	0.00205	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—CYP2E1—liver cancer	0.000375	0.00203	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—CDKN2A—liver cancer	0.000367	0.00199	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—CYCS—liver cancer	0.000351	0.0019	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—GGT1—liver cancer	0.000344	0.00186	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—GOT1—liver cancer	0.000344	0.00186	CbGpPWpGaD
Hydroxyurea—CYP2D6—Biological oxidations—CYP2E1—liver cancer	0.000344	0.00186	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metapathway biotransformation—CYP2E1—liver cancer	0.000339	0.00184	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—PSMA4—liver cancer	0.000338	0.00183	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—PSMD10—liver cancer	0.000338	0.00183	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—GOT2—liver cancer	0.000328	0.00178	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle—CDKN2A—liver cancer	0.000328	0.00178	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—CDKN1B—liver cancer	0.000325	0.00176	CbGpPWpGaD
Hydroxyurea—CYP2D6—Biological oxidations—GGT1—liver cancer	0.000316	0.00171	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—CCND1—liver cancer	0.00031	0.00168	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—GSTP1—liver cancer	0.000309	0.00167	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—CYP2E1—liver cancer	0.000309	0.00167	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—HMOX1—liver cancer	0.000305	0.00165	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—CDKN1A—liver cancer	0.0003	0.00162	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle—CDKN1B—liver cancer	0.000291	0.00157	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—CYCS—liver cancer	0.000289	0.00156	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—GSTM1—liver cancer	0.000284	0.00154	CbGpPWpGaD
Hydroxyurea—CYP2D6—Biological oxidations—GSTP1—liver cancer	0.000284	0.00153	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—GOT1—liver cancer	0.000283	0.00153	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—GGT1—liver cancer	0.000283	0.00153	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metapathway biotransformation—GSTP1—liver cancer	0.00028	0.00151	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle—CCND1—liver cancer	0.000277	0.0015	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—CYP1A1—liver cancer	0.000269	0.00146	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle—CDKN1A—liver cancer	0.000268	0.00145	CbGpPWpGaD
Hydroxyurea—CYP2D6—Biological oxidations—GSTM1—liver cancer	0.000261	0.00141	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metapathway biotransformation—GSTM1—liver cancer	0.000257	0.00139	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—GSTP1—liver cancer	0.000255	0.00138	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—MTHFR—liver cancer	0.000251	0.00136	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—HMOX1—liver cancer	0.000251	0.00136	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—MYC—liver cancer	0.000249	0.00135	CbGpPWpGaD
Hydroxyurea—CYP2D6—Biological oxidations—CYP1A1—liver cancer	0.000247	0.00134	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—PPARA—liver cancer	0.000246	0.00133	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metapathway biotransformation—CYP1A1—liver cancer	0.000244	0.00132	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—GSTM1—liver cancer	0.000234	0.00127	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle—MYC—liver cancer	0.000223	0.0012	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—CYP1A1—liver cancer	0.000222	0.0012	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—PIK3CG—liver cancer	0.000211	0.00114	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—MTHFR—liver cancer	0.000207	0.00112	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—PPARG—liver cancer	0.000204	0.0011	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—PPARA—liver cancer	0.000203	0.0011	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—PIK3CD—liver cancer	0.000185	0.001	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—UGDH—liver cancer	0.000185	0.001	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—ALB—liver cancer	0.000183	0.00099	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle—TP53—liver cancer	0.000183	0.000988	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—EPT1—liver cancer	0.000174	0.00094	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—PIK3CG—liver cancer	0.000174	0.00094	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—PPARG—liver cancer	0.000168	0.000907	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—TAT—liver cancer	0.000165	0.000891	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—PIK3CB—liver cancer	0.000162	0.000874	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—PIK3CD—liver cancer	0.000153	0.000826	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—ALB—liver cancer	0.000151	0.000816	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—PIK3CB—liver cancer	0.000133	0.00072	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—CPT1B—liver cancer	0.000112	0.000606	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—GLUL—liver cancer	0.000112	0.000606	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—NR1H4—liver cancer	0.000108	0.000584	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—GSTA3—liver cancer	0.000106	0.000574	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—PIK3CA—liver cancer	9.86e-05	0.000533	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—GSTA4—liver cancer	9.71e-05	0.000525	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—GSTA2—liver cancer	9.46e-05	0.000512	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—GSTA1—liver cancer	9.13e-05	0.000494	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—NAT2—liver cancer	9.03e-05	0.000488	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—ALDOB—liver cancer	8.65e-05	0.000468	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—CRABP1—liver cancer	8.26e-05	0.000447	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—PIK3CA—liver cancer	8.12e-05	0.000439	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—AKT1—liver cancer	8.05e-05	0.000435	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—HPGDS—liver cancer	7.22e-05	0.00039	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—AKT1—liver cancer	6.63e-05	0.000359	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—PSMD10—liver cancer	6.43e-05	0.000348	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—PSMA4—liver cancer	6.43e-05	0.000348	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—GOT2—liver cancer	6.26e-05	0.000338	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—CYP2E1—liver cancer	5.88e-05	0.000318	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—CYCS—liver cancer	5.5e-05	0.000298	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—GGT1—liver cancer	5.4e-05	0.000292	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—GOT1—liver cancer	5.4e-05	0.000292	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—GSTP1—liver cancer	4.85e-05	0.000262	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—HMOX1—liver cancer	4.78e-05	0.000259	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—GSTM1—liver cancer	4.46e-05	0.000241	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—CYP1A1—liver cancer	4.23e-05	0.000229	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—MTHFR—liver cancer	3.94e-05	0.000213	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—PPARA—liver cancer	3.87e-05	0.000209	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—PIK3CG—liver cancer	3.31e-05	0.000179	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—PPARG—liver cancer	3.2e-05	0.000173	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—PIK3CD—liver cancer	2.91e-05	0.000157	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—ALB—liver cancer	2.87e-05	0.000155	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—PIK3CB—liver cancer	2.54e-05	0.000137	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—PIK3CA—liver cancer	1.55e-05	8.36e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—AKT1—liver cancer	1.26e-05	6.83e-05	CbGpPWpGaD
